179 related articles for article (PubMed ID: 12435517)
1. Antiviral drugs: unapproved uses, dosages, or indications.
Rebora A
Clin Dermatol; 2002; 20(5):474-80. PubMed ID: 12435517
[No Abstract] [Full Text] [Related]
2. Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications.
Koo JY; Ng TC
Clin Dermatol; 2002; 20(5):582-94. PubMed ID: 12435529
[No Abstract] [Full Text] [Related]
3. Interferons: unapproved uses, dosages, or indications.
Orion E; Matz H; Wolf R
Clin Dermatol; 2002; 20(5):493-504. PubMed ID: 12435520
[No Abstract] [Full Text] [Related]
4. Antifungal agents: unapproved uses, dosages, or indications.
Sehgal VN; Khandpur S
Clin Dermatol; 2002; 20(5):481-9. PubMed ID: 12435518
[No Abstract] [Full Text] [Related]
5. Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications.
Wolf R; Matz H; Orion E; Tüzün B; Tüzün Y
Clin Dermatol; 2002; 20(5):531-46. PubMed ID: 12435524
[No Abstract] [Full Text] [Related]
6. Topical vitamin D3 analogues: unapproved uses, dosages, or indications.
Parish JL
Clin Dermatol; 2002; 20(5):558-62. PubMed ID: 12435526
[No Abstract] [Full Text] [Related]
7. Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.
Wolf R; Orion E; Matz H; Tüzün Y; Tüzün B
Clin Dermatol; 2002; 20(5):547-57. PubMed ID: 12435525
[No Abstract] [Full Text] [Related]
8. Photodynamic therapy: unapproved uses, dosages, or indications.
Salva KA
Clin Dermatol; 2002; 20(5):571-81. PubMed ID: 12435528
[No Abstract] [Full Text] [Related]
9. Topical immunotherapy: unapproved uses, dosages, or indications.
Higgins E; du Vivier A
Clin Dermatol; 2002; 20(5):515-21. PubMed ID: 12435522
[No Abstract] [Full Text] [Related]
10. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
Assmann T; Ruzicka T
Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
[No Abstract] [Full Text] [Related]
11. Topical corticosteroids: unapproved uses, dosages, or indications.
Lagos BR; Maibach HI
Clin Dermatol; 2002; 20(5):490-2. PubMed ID: 12435519
[No Abstract] [Full Text] [Related]
12. Commentary: unapproved uses, dosages, or indications in dermatology: a physician's reference.
Wolf R
Clin Dermatol; 2002; 20(5):465-6. PubMed ID: 12435515
[No Abstract] [Full Text] [Related]
13. Antiviral drugs.
Treat Guidel Med Lett; 2013 Mar; 11(127):19-30. PubMed ID: 23459414
[No Abstract] [Full Text] [Related]
14. FDA recommends hepatitis B drug.
AIDS Patient Care STDS; 2002 Oct; 16(10):511. PubMed ID: 12437861
[No Abstract] [Full Text] [Related]
15. Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.
Riner A; Chan-Tack KM; Murray JS
Postgrad Med; 2009 May; 121(3):139-46. PubMed ID: 19491552
[TBL] [Abstract][Full Text] [Related]
16. Is Minocycline an Antiviral Agent? A Review of Current Literature.
Nagarakanti S; Bishburg E
Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):4-8. PubMed ID: 26177421
[TBL] [Abstract][Full Text] [Related]
17. Unapproved uses of approved drugs.
Coté CJ
Paediatr Anaesth; 1997; 7(2):91-2. PubMed ID: 9188107
[No Abstract] [Full Text] [Related]
18. Recap of FDA product approvals--2001.
Traynor K
Am J Health Syst Pharm; 2002 Feb; 59(4):321-2, 324. PubMed ID: 11885393
[No Abstract] [Full Text] [Related]
19. Ropinirole (Requip) for restless legs syndrome.
Obstet Gynecol; 2006 Jan; 107(1):176-8. PubMed ID: 16394057
[No Abstract] [Full Text] [Related]
20. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
Arya V; Carter WW; Robertson SM
Clin Pharmacol Ther; 2010 Nov; 88(5):587-9. PubMed ID: 20959843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
